|
|
| (11) | Number of the document | C 2340031 |
| (68) | Number of the document | 2340031 |
| (21) | Application number for Supplementary Protection Certificate | PA 2020 006 |
| (22) | Date of filing the application | 2020-12-17 |
| (41) | Date of publication of the application | 2021-01-11 |
| Date of publication of SPC | 2022-06-27 | |
| (24) | Date of coming into effect of SPC | 2029-08-14 |
| (71) |
Acceleron Pharma Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (73) |
Acceleron Pharma Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/20/1452, 2020-06-25 |
| (94) | 2034-08-13 |
| (95) | Luspaterceptas |
| SPC granted |